Results 1 to 10 of about 1,097,723 (197)
Some of the next articles are maybe not open access.
Endothelial Receptor Tyrosine Kinases Involved in Angiogenesis.
Journal of Cell Biology, 1995Kari Alitalo
exaly
The Evolving Field of Tyrosine Kinase Inhibitors in the Treatment of Endocrine Tumors
Endocrine Reviews, 2010Libero Santarpia, Robert F Gagel
exaly
Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?
Trends in Endocrinology and Metabolism, 2015Athanasios Fountas +1 more
exaly
Tyrosine Kinases as Targets in Cancer Therapy – Successes and Failures
Expert Opinion on Therapeutic Targets, 2003Peter Traxler
exaly
The Discovery of Receptor Tyrosine Kinases: Targets for Cancer Therapy
Nature Reviews Cancer, 2004Oliver M Fischer +2 more
exaly
TYROSINE KINASE INHIBITORS AND INTERFERON
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was considered as a breakthrough in the therapy of this disease; INF administered alone or in combination with aracytine was the standard choice for treatment for
Maria Dimou, Panagiotis Panagiotidis
doaj +4 more sources

